June 17, 2014 – Boehringer and Lilly announce resubmission of NDA for empagliflozin.
Jun 2014 – NDA resubmission announced
Announcement Date: June 17, 2014
June 17, 2014 – Boehringer and Lilly announce resubmission of NDA for empagliflozin.